We are an investment house with Belgian roots founded on more than 150 years of trust.
As a private company owned by long-term committed shareholders, we are independent. Naturally and structurally. Our experts have the knowledge to think and act without bias, and to make decisions that benefit our clients. Today and tomorrow.
BUSINESS ACCOUNT
Access reports individually or via Subscription
Receive monthly invoices with payment via CSA or hard dollars
Analyst access
Free Trial Subscriptions
Team account with shared subscriptions
Advanced analytics to track research consumption and performance
Unique model with stable high marginsStable return by matching production and consumption. EnergyVision has developed a unique model based on green solar energy, where it matches production and consumption to create attractive stable returns. Its long-term contracts with consumers give it good visibility on the prices at which it sells its solar energy. Customers benefit from attractive prices and lower vulnerability to future price hikes.EV chargers bring even better matching. With the launch o...
Scaling up its succesful station approachRolling out tried-and-tested concept. Fastned is a clear market leader in highway fast charging in the Netherlands. In the past years it has optimized its concept to provide market-leading reliability and a high service level to customers at competitive costs. It is now rolling out this concept to other European countries, aiming to grow from 346 stations at YE2024 to 1,000 stations by 2030.Significant operating leverage. The stations have been operating ...
Today, we initiate coverage on Biotalys, a Belgian regulatory-stage agricultural biotech (AgBiotech) company, with a BUY rating & TP of EUR 7.2.In this report, we deep-dive into the company's differentiated AGROBODY FoundryTM platform and the unique value-add of its protein-based biocontrols (AGROBODIESTM) meant to treat fungal diseases affecting fruits & vegetables. We consider Biotalys a compelling investment opportunity, based on:1/ Growing awareness on the impact of chemical crop protec...
Whitestone launched its annual report for FY24 including some important improvement to its transparency to shareholdersWith the disclosure of a NAV overview and more financial data per portfolio company, Whitestone's transparency is now in line with some of the biggest investment companies in EuropeWe estimate today's NAV to be EUR 16.2 p/s, implying a discount of 20.5%. Our target valuation comes in at EUR 17 p/s. Applying our target discount of 10%, we arrive at our new TP of EUR 15 ...
In Q1-25, ForFarmers continued to deliver on strategy with positive LFL volume and earnings growth. ROACE came in at 13.8%, in line with FY ‘24.We maintain our Hold rating, and 12m TP of EUR 5.3. Company continues to perform well, solidly executing its strategy. However, market conditions and the consolidation of the feed activities of team agra/HaBeMa create some lower visibility. Hence our Hold rating.
